FDA Approval Expected to Set Off Legal Battle
In a move likely to set off a tidal wave of litigation, the U.S. Food and Drug Administration approved a generic version of Pfizer's hypertension medication Norvasc by Indian generics maker...To view the full article, register now.
Already a subscriber? Click here to view full article